Cite
HARVARD Citation
Zhang, W. et al. (2020). Absolute Bioavailability of Vemurafenib in Patients With BRAFV600 Mutation–Positive Malignancies. Clinical pharmacology in drug development. 9 (4), pp. 496-504. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zhang, W. et al. (2020). Absolute Bioavailability of Vemurafenib in Patients With BRAFV600 Mutation–Positive Malignancies. Clinical pharmacology in drug development. 9 (4), pp. 496-504. [Online].